Donald Brautigam, MD
Family Medicine · Westfield, NYNPI 1407821986
Payments from drug & device makers
Across 3,047 payments — averaging $430.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$956K
- Eli Lilly$294K
- Lexicon Pharmaceuticals, Inc.$43K
- Boehringer Ingelheim Pharma GmbH & Co.kg$7K
- Novo Nordisk$6K
- Boehringer Ingelheim$6K
- plus $932 from 17 others
Across 30 payments — averaging $206.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$5K
- Eli Lilly$834
- Novo Nordisk$25
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 2,936 | $955,651 |
| Eli Lilly | 36 | $294,305 |
| Lexicon Pharmaceuticals, Inc. | 16 | $43,188 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $6,677 |
| Novo Nordisk | 16 | $6,207 |
| Boehringer Ingelheim | 2 | $5,963 |
| Boehringer Ingelheim International GmbH | 8 | $372 |
| GSK | 5 | $91 |
| Pfizer | 5 | $86 |
| AstraZeneca | 4 | $60 |
| Lilly USA, LLC | 4 | $60 |
| Bayer | 2 | $47 |
| Amgen | 2 | $34 |
| Boston Scientific | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Advanced Oxygen Therapy Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Merck | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| AbbVie | 1 | $15 |
| Abbott | 1 | $12 |
How this compares
$1,312,923 in reported general payments places this provider in the 95th percentile of 4,321 family medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Westfield
- Timothy KitchenWestfield$142K
- Timothy GormanWestfield$116K
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
- Suchet PatelEndwell$23.3M
- James WildGowanda$2.2M
- Michael FedericoEndwell$1.4M
- Kimberly DesantisEndwell$1.1M
- Michael TugetmanHartsdale$1M
- Richard RuhOrchard Park$769K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.